Moreover, bioinformatics analyses have suggested that ARPC5 expression is significantly increased in multiple myeloma (MM) cells compared with normal plasma cells, and high expression of ARPC5 is associated with poor overall survival (OS) in patients with MM. The gene discussed is ARPC5; the disease is plasma cell myeloma.